Oiling  ||| S:0 E:7 ||| VBG
the  ||| S:7 E:11 ||| DT
wheels  ||| S:11 E:18 ||| NNS
of  ||| S:18 E:21 ||| IN
intensive  ||| S:21 E:31 ||| JJ
care  ||| S:31 E:36 ||| NN
to  ||| S:36 E:39 ||| TO
reduce  ||| S:39 E:46 ||| VB
machine  ||| S:46 E:54 ||| NN
friction ||| S:54 E:62 ||| NN
:  ||| S:62 E:64 ||| :
the  ||| S:64 E:68 ||| DT
best  ||| S:68 E:73 ||| JJS
way  ||| S:73 E:77 ||| NN
to  ||| S:77 E:80 ||| TO
improve  ||| S:80 E:88 ||| VB
outcomes ||| S:88 E:96 ||| NNS
?  ||| S:96 E:98 ||| .
A  ||| S:98 E:100 ||| DT
number  ||| S:100 E:107 ||| NN
of  ||| S:107 E:110 ||| IN
costly  ||| S:110 E:117 ||| JJ
trials  ||| S:117 E:124 ||| NNS
of  ||| S:124 E:127 ||| IN
interventions  ||| S:127 E:141 ||| NNS
for  ||| S:141 E:145 ||| IN
the  ||| S:145 E:149 ||| DT
critically  ||| S:149 E:160 ||| JJ
ill  ||| S:160 E:164 ||| NNS
have  ||| S:164 E:169 ||| VBP
had  ||| S:169 E:173 ||| VBN
results  ||| S:173 E:181 ||| NNS
that  ||| S:181 E:186 ||| WDT
are  ||| S:186 E:190 ||| VBP
initially  ||| S:190 E:200 ||| RB
positive ||| S:200 E:208 ||| JJ
,  ||| S:208 E:210 ||| ,
and  ||| S:210 E:214 ||| CC
then  ||| S:214 E:219 ||| RB
subsequent  ||| S:219 E:230 ||| JJ
trials  ||| S:230 E:237 ||| NNS
are  ||| S:237 E:241 ||| VBP
less  ||| S:241 E:246 ||| RBR
positive ||| S:246 E:254 ||| JJ
.  ||| S:254 E:256 ||| .
This  ||| S:256 E:261 ||| DT
has  ||| S:261 E:265 ||| VBZ
led  ||| S:265 E:269 ||| VBN
to  ||| S:269 E:272 ||| TO
uncertainty  ||| S:272 E:284 ||| NN
and  ||| S:284 E:288 ||| CC
a  ||| S:288 E:290 ||| DT
feeling  ||| S:290 E:298 ||| NN
that  ||| S:298 E:303 ||| IN
our  ||| S:303 E:307 ||| PRP$
scientific  ||| S:307 E:318 ||| JJ
approach  ||| S:318 E:327 ||| NN
may  ||| S:327 E:331 ||| MD
need  ||| S:331 E:336 ||| VB
reevaluation ||| S:336 E:348 ||| NNS
.  ||| S:348 E:350 ||| .
What  ||| S:350 E:355 ||| WP
are  ||| S:355 E:359 ||| VBP
we  ||| S:359 E:362 ||| PRP
missing  ||| S:362 E:370 ||| VBG
when  ||| S:370 E:375 ||| WRB
performing  ||| S:375 E:386 ||| VBG
these  ||| S:386 E:392 ||| DT
trials ||| S:392 E:398 ||| NNS
?  ||| S:398 E:400 ||| .
Are  ||| S:400 E:404 ||| VBP
there  ||| S:404 E:410 ||| RB
simple ||| S:410 E:416 ||| JJ
,  ||| S:416 E:418 ||| ,
less  ||| S:418 E:423 ||| RBR
costly  ||| S:423 E:430 ||| JJ
ways  ||| S:430 E:435 ||| NNS
of  ||| S:435 E:438 ||| IN
improving  ||| S:438 E:448 ||| VBG
outcomes  ||| S:448 E:457 ||| NNS
for  ||| S:457 E:461 ||| IN
patients ||| S:461 E:469 ||| NNS
?  ||| S:469 E:471 ||| .
Many  ||| S:471 E:476 ||| JJ
of  ||| S:476 E:479 ||| IN
the  ||| S:479 E:483 ||| DT
large  ||| S:483 E:489 ||| JJ
interventional  ||| S:489 E:504 ||| JJ
trials  ||| S:504 E:511 ||| NNS
have  ||| S:511 E:516 ||| VBP
included  ||| S:516 E:525 ||| VBN
patients  ||| S:525 E:534 ||| NNS
on  ||| S:534 E:537 ||| IN
the  ||| S:537 E:541 ||| DT
basis  ||| S:541 E:547 ||| NN
of  ||| S:547 E:550 ||| IN
syndromic  ||| S:550 E:560 ||| JJ
enrollment  ||| S:560 E:571 ||| NN
criteria ||| S:571 E:579 ||| NNS
.  ||| S:579 E:581 ||| .
This  ||| S:581 E:586 ||| DT
inevitably  ||| S:586 E:597 ||| RB
leads  ||| S:597 E:603 ||| VBZ
to  ||| S:603 E:606 ||| TO
a  ||| S:606 E:608 ||| DT
heterogeneous  ||| S:608 E:622 ||| JJ
profile  ||| S:622 E:630 ||| NN
of  ||| S:630 E:633 ||| IN
patients ||| S:633 E:641 ||| NNS
,  ||| S:641 E:643 ||| ,
precipitating  ||| S:643 E:657 ||| VBG
conditions ||| S:657 E:667 ||| NNS
,  ||| S:667 E:669 ||| ,
and  ||| S:669 E:673 ||| CC
chronic  ||| S:673 E:681 ||| JJ
health ||| S:681 E:687 ||| NN
.  ||| S:687 E:689 ||| .
The  ||| S:689 E:693 ||| DT
realistic  ||| S:693 E:703 ||| JJ
effect  ||| S:703 E:710 ||| NN
of  ||| S:710 E:713 ||| IN
an  ||| S:713 E:716 ||| DT
intervention  ||| S:716 E:729 ||| NN
may  ||| S:729 E:733 ||| MD
vary  ||| S:733 E:738 ||| VB
depending  ||| S:738 E:748 ||| VBG
on  ||| S:748 E:751 ||| IN
the  ||| S:751 E:755 ||| DT
individual  ||| S:755 E:766 ||| JJ
circumstances  ||| S:766 E:780 ||| NNS
of  ||| S:780 E:783 ||| IN
a  ||| S:783 E:785 ||| DT
particular  ||| S:785 E:796 ||| JJ
patient ||| S:796 E:803 ||| NN
,  ||| S:803 E:805 ||| ,
contributing  ||| S:805 E:818 ||| VBG
to  ||| S:818 E:821 ||| TO
trial  ||| S:821 E:827 ||| NN
noise ||| S:827 E:832 ||| NN
.  ||| S:832 E:834 ||| .
The  ||| S:834 E:838 ||| DT
assumption  ||| S:838 E:849 ||| NN
that  ||| S:849 E:854 ||| IN
trial  ||| S:854 E:860 ||| NN
size  ||| S:860 E:865 ||| NN
and  ||| S:865 E:869 ||| CC
randomization  ||| S:869 E:883 ||| NNS
will  ||| S:883 E:888 ||| MD
deal  ||| S:888 E:893 ||| VB
with  ||| S:893 E:898 ||| IN
this  ||| S:898 E:903 ||| DT
may  ||| S:903 E:907 ||| MD
not  ||| S:907 E:911 ||| RB
hold  ||| S:911 E:916 ||| VB
true  ||| S:916 E:921 ||| JJ
and  ||| S:921 E:925 ||| CC
in  ||| S:925 E:928 ||| IN
some  ||| S:928 E:933 ||| DT
circumstances  ||| S:933 E:947 ||| NNS
may  ||| S:947 E:951 ||| MD
be  ||| S:951 E:954 ||| VB
biologically  ||| S:954 E:967 ||| JJ
questionable ||| S:967 E:979 ||| JJ
.  ||| S:979 E:981 ||| .
Perhaps  ||| S:981 E:989 ||| RB
we  ||| S:989 E:992 ||| PRP
should  ||| S:992 E:999 ||| MD
consider  ||| S:999 E:1008 ||| VB
alternatives ||| S:1008 E:1020 ||| NNS
?  ||| S:1020 E:1022 ||| .
In  ||| S:1022 E:1025 ||| IN
common  ||| S:1025 E:1032 ||| JJ
with  ||| S:1032 E:1037 ||| IN
other  ||| S:1037 E:1043 ||| JJ
areas  ||| S:1043 E:1049 ||| NNS
of  ||| S:1049 E:1052 ||| IN
medicine ||| S:1052 E:1060 ||| NN
,  ||| S:1060 E:1062 ||| ,
it  ||| S:1062 E:1065 ||| PRP
is  ||| S:1065 E:1068 ||| VBZ
well-known  ||| S:1068 E:1079 ||| JJ
that  ||| S:1079 E:1084 ||| IN
intensive  ||| S:1084 E:1094 ||| JJ
care  ||| S:1094 E:1099 ||| NN
outcomes  ||| S:1099 E:1108 ||| NNS
are  ||| S:1108 E:1112 ||| VBP
variable ||| S:1112 E:1120 ||| VBN
,  ||| S:1120 E:1122 ||| ,
reflecting  ||| S:1122 E:1133 ||| VBG
differing  ||| S:1133 E:1143 ||| JJ
performance ||| S:1143 E:1154 ||| NN
.  ||| S:1154 E:1156 ||| .
Until  ||| S:1156 E:1162 ||| IN
recently ||| S:1162 E:1170 ||| RB
,  ||| S:1170 E:1172 ||| ,
little  ||| S:1172 E:1179 ||| JJ
attention  ||| S:1179 E:1189 ||| NN
has  ||| S:1189 E:1193 ||| VBZ
been  ||| S:1193 E:1198 ||| VBN
focused  ||| S:1198 E:1206 ||| VBN
on  ||| S:1206 E:1209 ||| IN
a  ||| S:1209 E:1211 ||| DT
detailed  ||| S:1211 E:1220 ||| JJ
understanding  ||| S:1220 E:1234 ||| NN
of  ||| S:1234 E:1237 ||| IN
variation  ||| S:1237 E:1247 ||| NN
in  ||| S:1247 E:1250 ||| IN
performance  ||| S:1250 E:1262 ||| NN
and  ||| S:1262 E:1266 ||| CC
delivery  ||| S:1266 E:1275 ||| NN
of  ||| S:1275 E:1278 ||| IN
care  ||| S:1278 E:1283 ||| NN
and  ||| S:1283 E:1287 ||| CC
how  ||| S:1287 E:1291 ||| WRB
such  ||| S:1291 E:1296 ||| JJ
knowledge  ||| S:1296 E:1306 ||| NN
might  ||| S:1306 E:1312 ||| MD
be  ||| S:1312 E:1315 ||| VB
used  ||| S:1315 E:1320 ||| VBN
to  ||| S:1320 E:1323 ||| TO
improve  ||| S:1323 E:1331 ||| VB
patient  ||| S:1331 E:1339 ||| JJ
outcomes ||| S:1339 E:1347 ||| NNS
.  ||| S:1347 E:1349 ||| .
A  ||| S:1349 E:1351 ||| DT
number  ||| S:1351 E:1358 ||| NN
of  ||| S:1358 E:1361 ||| IN
recent  ||| S:1361 E:1368 ||| JJ
efforts  ||| S:1368 E:1376 ||| NNS
that  ||| S:1376 E:1381 ||| WDT
have  ||| S:1381 E:1386 ||| VBP
demonstrated  ||| S:1386 E:1399 ||| VBN
positive  ||| S:1399 E:1408 ||| JJ
improvements  ||| S:1408 E:1421 ||| NNS
have  ||| S:1421 E:1426 ||| VBP
been  ||| S:1426 E:1431 ||| VBN
based  ||| S:1431 E:1437 ||| VBN
around  ||| S:1437 E:1444 ||| IN
understanding  ||| S:1444 E:1458 ||| NN
and  ||| S:1458 E:1462 ||| CC
reducing  ||| S:1462 E:1471 ||| VBG
individual  ||| S:1471 E:1482 ||| JJ
and  ||| S:1482 E:1486 ||| CC
organizational  ||| S:1486 E:1501 ||| JJ
underperformance ||| S:1501 E:1517 ||| NN
.  ||| S:1517 E:1519 ||| .
This  ||| S:1519 E:1524 ||| DT
human  ||| S:1524 E:1530 ||| JJ
and  ||| S:1530 E:1534 ||| CC
organizational  ||| S:1534 E:1549 ||| JJ
factors-based  ||| S:1549 E:1563 ||| JJ
research  ||| S:1563 E:1572 ||| NN
does  ||| S:1572 E:1577 ||| VBZ
not  ||| S:1577 E:1581 ||| RB
conflict  ||| S:1581 E:1590 ||| NN
with  ||| S:1590 E:1595 ||| IN
more  ||| S:1595 E:1600 ||| RBR
pharmacologic-based  ||| S:1600 E:1620 ||| JJ
research  ||| S:1620 E:1629 ||| NN
and  ||| S:1629 E:1633 ||| CC
may  ||| S:1633 E:1637 ||| MD
be  ||| S:1637 E:1640 ||| VB
complimentary ||| S:1640 E:1653 ||| NNS
.  ||| S:1653 E:1655 ||| .
By  ||| S:1655 E:1658 ||| IN
properly  ||| S:1658 E:1667 ||| RB
understanding  ||| S:1667 E:1681 ||| VBG
the  ||| S:1681 E:1685 ||| DT
way  ||| S:1685 E:1689 ||| NN
we  ||| S:1689 E:1692 ||| PRP
do  ||| S:1692 E:1695 ||| VBP
things  ||| S:1695 E:1702 ||| NNS
and  ||| S:1702 E:1706 ||| CC
the  ||| S:1706 E:1710 ||| DT
optimal  ||| S:1710 E:1718 ||| JJ
local  ||| S:1718 E:1724 ||| JJ
balance  ||| S:1724 E:1732 ||| NN
of  ||| S:1732 E:1735 ||| IN
protocolized  ||| S:1735 E:1748 ||| NN
and  ||| S:1748 E:1752 ||| CC
individualized  ||| S:1752 E:1767 ||| JJ
care ||| S:1767 E:1771 ||| NN
,  ||| S:1771 E:1773 ||| ,
we  ||| S:1773 E:1776 ||| PRP
may  ||| S:1776 E:1780 ||| MD
deliver  ||| S:1780 E:1788 ||| VB
greater  ||| S:1788 E:1796 ||| JJR
improvements  ||| S:1796 E:1809 ||| NNS
to  ||| S:1809 E:1812 ||| TO
the  ||| S:1812 E:1816 ||| DT
outcome  ||| S:1816 E:1824 ||| NN
of  ||| S:1824 E:1827 ||| IN
intensive  ||| S:1827 E:1837 ||| JJ
care  ||| S:1837 E:1842 ||| NN
unit  ||| S:1842 E:1847 ||| NN
patients  ||| S:1847 E:1856 ||| NNS
than  ||| S:1856 E:1861 ||| IN
many  ||| S:1861 E:1866 ||| JJ
of  ||| S:1866 E:1869 ||| IN
the  ||| S:1869 E:1873 ||| DT
more  ||| S:1873 E:1878 ||| RBR
expensive ||| S:1878 E:1887 ||| JJ
,  ||| S:1887 E:1889 ||| ,
pharmacologic ||| S:1889 E:1902 ||| NN
,  ||| S:1902 E:1904 ||| ,
and  ||| S:1904 E:1908 ||| CC
technological  ||| S:1908 E:1922 ||| JJ
attempts  ||| S:1922 E:1931 ||| NNS
of  ||| S:1931 E:1934 ||| IN
recent  ||| S:1934 E:1941 ||| JJ
years ||| S:1941 E:1946 ||| NNS
.  ||| S:1946 E:1948 ||| .
